US 8247555
Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
granted A61KA61K31/46A61K31/485
Quick answer
US patent 8247555 (Crystalline forms of an 8-azabicyclo[3.2.1]octane compound) held by Theravance, Inc. expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/46, A61K31/485, A61K45/06, A61P